Dr. Nathan Bahary, MD, PhD
Claim this profileGSK Investigational Site
Studies Pancreatic Cancer
Studies Colorectal Cancer
10 reported clinical trials
28 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
2Colorectal Cancer
Stage IV
dMMR positive
MSI-H positive
Affiliated Hospitals
Clinical Trials Nathan Bahary, MD, PhD is currently running
Combination Therapy
for Pancreatic Cancer
This trial tests a new drug, AB680, combined with three other drugs in patients with advanced pancreatic cancer. The goal is to enhance the immune system's response and use chemotherapy to fight the cancer.
Recruiting1 award Phase 114 criteria
Azeliragon
for Refractory Pancreatic Cancer
This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to prior treatment of metastatic pancreatic cancer.
Recruiting1 award Phase 1 & 28 criteria
More about Nathan Bahary, MD, PhD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Nathan Bahary, MD, PhD has experience with
- Gemcitabine
- Cisplatin
- Nab-paclitaxel
- Carboplatin
- Ipilimumab
- 9-ING-41
Breakdown of trials Nathan Bahary, MD, PhD has run
Pancreatic Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nathan Bahary, MD, PhD specialize in?
Nathan Bahary, MD, PhD focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nathan Bahary, MD, PhD currently recruiting for clinical trials?
Yes, Nathan Bahary, MD, PhD is currently recruiting for 3 clinical trials in Monroeville Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Nathan Bahary, MD, PhD has studied deeply?
Yes, Nathan Bahary, MD, PhD has studied treatments such as Gemcitabine, Cisplatin, Nab-paclitaxel.
What is the best way to schedule an appointment with Nathan Bahary, MD, PhD?
Apply for one of the trials that Nathan Bahary, MD, PhD is conducting.
What is the office address of Nathan Bahary, MD, PhD?
The office of Nathan Bahary, MD, PhD is located at: GSK Investigational Site, Monroeville, Pennsylvania 15146 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.